Aveanna Healthcare (NASDAQ:AVAH – Get Rating) had its target price decreased by Stephens to $2.50 in a research report report published on Tuesday, Stock Target Advisor reports.
AVAH has been the subject of several other reports. Jefferies Financial Group lowered shares of Aveanna Healthcare from a buy rating to a hold rating and set a $2.50 price objective for the company. in a research note on Friday, July 22nd. Bank of America lowered shares of Aveanna Healthcare from a neutral rating to an underperform rating and dropped their price objective for the stock from $3.00 to $2.00 in a research note on Tuesday, June 21st. Credit Suisse Group dropped their price objective on shares of Aveanna Healthcare to $5.50 in a research note on Friday, July 22nd. Barclays dropped their price objective on shares of Aveanna Healthcare from $7.00 to $5.00 and set an overweight rating for the company in a research note on Friday, August 19th. Finally, Truist Financial lowered shares of Aveanna Healthcare from a buy rating to a hold rating and set a $2.50 price objective for the company. in a research note on Tuesday, July 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Aveanna Healthcare has a consensus rating of Moderate Buy and a consensus price target of $5.30.
Get
Aveanna Healthcare alerts:
Aveanna Healthcare Trading Up 1.2 %
AVAH stock opened at $1.69 on Tuesday. The firm has a fifty day moving average price of $2.23 and a 200 day moving average price of $3.19. Aveanna Healthcare has a fifty-two week low of $1.66 and a fifty-two week high of $9.73. The company has a debt-to-equity ratio of 6.19, a quick ratio of 0.81 and a current ratio of 0.81. The firm has a market cap of $314.20 million, a PE ratio of -0.56 and a beta of 1.03.
Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last posted its earnings results on Wednesday, August 10th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by ($0.03). Aveanna Healthcare had a negative net
margin of 33.32% and a positive return on equity of 9.57%. During the same quarter in the previous year, the business earned $0.08 earnings per share. Sell-side analysts anticipate that Aveanna Healthcare will post 0.16 earnings per share for the current fiscal year.
Institutional Trading of Aveanna Healthcare
Institutional investors and hedge funds have recently made changes to their positions in the company. Regentatlantic Capital LLC purchased a new stake in shares of Aveanna Healthcare during the first quarter worth about $34,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $25,000. AE Wealth Management LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $31,000. Virginia Retirement Systems ET AL purchased a new stake in shares of Aveanna Healthcare during the first quarter worth about $50,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $38,000. 92.00% of the stock is currently owned by institutional investors.
About Aveanna Healthcare
(Get Rating)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
See Also
- Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
- 3 Low Beta Defensive Stocks for a Tough Market
- It Could Be a September to Remember for These 3 Stocks
- Peak Inflation Sets the Bottom for Brinker International Stock
- Can Roblox Reverse its Falling Bookings Amid Rising Engagements
- Broadcom Bounces From Institutional Bottom
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
